Dr. Postow on Entrectinib in Melanoma

(1:16)

Dr. Postow on Combination Regimens for High-Risk Melanoma

(1:17)

Dr. Postow on FDA Approval of Adjuvant Dabrafenib Plus Trametinib in BRAF-Mutant Melanoma

(30)

Dr. Postow on FDA Approval of Cemiplimab in Metastatic Cutaneous Squamous Cell Carcinoma

(33)

Dr. Postow on Immunotherapy Advancements in Melanoma

(1:17)

Oncologist-to-Oncologist: How to Treat Your Patients with Immunotherapy

(55:22)

Osteosarcoma: My Insight into Diagnosis, Limb-Sparing Surgical Management, and Postoperative Care

(11:33)

ASCO 2024: Advances in Melanoma and Related Cancers

(1:2:27)

Abnormal Breath Sounds | Respiratory System

(17:17)

Bone Healing: Foundation Considerations Revisited – Stephen Lockey, MD

(1:29:47)

Immunotherapy for cancer treatment: New Hope or More Hype?

(10:27)

Living with multiple myeloma

(2:16)

How to Make the Most of Stage IV Decision Making for Patients and Caregivers

(36:38)

Cancer Immunotherapy - PD-1 and PD-L1

(4:)

Physiological pathological breath sounds

(6:4)

BREATH SOUNDS- WHAT DOES PNEUMONIA SOUND LIKE?

(1:46)

Dr. Postow on the Current Treatment Landscape in Melanoma

(1:18)

Dr. Postow Discusses Combination Therapy for Melanoma

(1:17)

Dr. Postow on Nivolumab Combined With Ipilimumab in Melanoma

(1:15)

Dr. Postow on BRAF and MEK Inhibitor Combination Studies in Melanoma

(1:19)

Dr. Postow on Advancements of Immunotherapy in Melanoma

(1:20)

Dr. Postow on OS Results of CheckMate-069 Study

(57)

New Checkpoint Inhibitors \u0026 Immunotherapy in Metastatic Melanoma - Michael Postow MD

(23:20)

Dr. Michael A. Postow on the Treatment of Melanoma-Related Toxicities

(1:8)

Dr. Postow on Using PD-L1 as a Biomarker of Response

(1:14)

Evaluating the Use of Immune Checkpoint Inhibitors in Melanoma

(14:32)

2013 OncPrac Summit: Michael Postow on immuno- and targeted therapies for melanoma

(5:29)

Ask the Expert - My Melanoma Therapy Stopped Working: What's Next?

(57:55)

Dr. Postow Discusses New Targets in Melanoma

(59)